Related Experiment Video
Updated: Mar 20, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Protease Inhibitors in View of Peptide Substrate Databases
Birgit J Waldner1, Julian E Fuchs1, Michael Schauperl1
1Institute of General, Inorganic and Theoretical Chemistry, University of Innsbruck , Innrain 82, 6020 Innsbruck, Austria.
This study introduces a novel shape-based virtual screening method to discover protease inhibitors. It leverages protease specificity data from the MEROPS database, offering an efficient alternative to traditional drug discovery approaches.
Area of Science:
- Biochemistry
- Computational Chemistry
- Drug Discovery
Background:
- Protease substrate profiling is a routine experimental task.
- MEROPS database provides accessible knowledge on protease peptide substrates.
Purpose of the Study:
- To develop a shape-based virtual screening workflow using vROCS.
- To identify new small-molecule protease inhibitors by applying protease specificity information.
Main Methods:
- Utilized peptide substrate sequences from MEROPS for training set construction.
- Converted 2D substrate sequences to 3D conformations via template mutation.
- Built vROCS queries from single amino acid queries considering relative frequencies.
Main Results:
- Demonstrated good performance for thrombin, factor Xa, factor VIIa, and caspase-3 using the DUD-E dataset.
- Validated method's effectiveness across proteases with diverse specificity and active-site mechanisms.
Conclusions:
- The peptide-substrate-based virtual screening approach is effective for protease inhibitor discovery.
- This method offers significant advantages by not requiring target structure or known inhibitor information.
Related Concept Videos
Protein-protein Interfaces
Dipeptidyl Peptidase 4 Inhibitors
The Proteasome Structure
The proteasome is an...

